In patients with metabolic-associated steatotic liver disease or metabolic-associated steatohepatitis, resmetirom and ...

These organizations can help you educate yourself, spread awareness, and connect with the MASH community to help you better manage your health.

GLP-1 RAs are associated with a modestly increased risk for GERD and gallstone disease but not with GI and biliary complications.

Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the ...

The pathogenesis of tendinopathy and the primary biological change in the tendon that precipitates pathology have generated several pathoaetiological models in the literature. The continuum model of ...

Background: Non-alcoholic-steatohepatitis (NASH) leading to fibrosis, end-stage cirrhosis and hepatocellular carcinoma is an increasing health problem in the Western world. Thus, the need for new ...

POXEL SA (Euronext: POXEL FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology ...

Adding more salt to food is linked to increased risks for liver diseases, such as MASLD and cirrhosis, as well as cancer.

Non-alcoholic steatohepatitis (NASH) is a condition characterized by accumulation of fat, inflammation and injury in liver cells in people who consume little or no alcohol.

NMU previously offered a master’s degree in speech-language pathology until 2003, and is now reinstating the program in response to growing regional demand for services and qualified providers. “At ...

This study investigates potential therapeutic targets for osteoporosis using a multiomics approach and explores the dual role of androgen receptor (AR) signaling in its pathophysiology. By analyzing ...